LABD vs. TZA
LABD (Direxion Daily S&P Biotech Bear 3x Shares) and TZA (Direxion Daily Small Cap Bear 3X Shares) are both Leveraged Equities funds from Direxion - LABD tracks the S&P Biotechnology Select Industry Index (-300%) while TZA tracks the Russell 2000 Index (-300%). Both are passively managed. Over the past 10 years, LABD returned -59.09%/yr vs -44.17%/yr for TZA. A 0.70 correlation means they provide meaningful diversification when combined. LABD charges 1.06%/yr vs 1.11%/yr for TZA.
Performance
LABD vs. TZA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LABD achieves a -53.78% return, which is significantly lower than TZA's -46.35% return. Over the past 10 years, LABD has underperformed TZA with an annualized return of -59.09%, while TZA has yielded a comparatively higher -44.17% annualized return.
LABD
- 1D
- -3.10%
- 1M
- -32.29%
- YTD
- -53.78%
- 6M
- -50.39%
- 1Y
- -87.04%
- 3Y*
- -56.99%
- 5Y*
- -43.25%
- 10Y*
- -59.09%
TZA
- 1D
- 2.05%
- 1M
- -12.69%
- YTD
- -46.35%
- 6M
- -42.28%
- 1Y
- -67.58%
- 3Y*
- -46.88%
- 5Y*
- -30.52%
- 10Y*
- -44.17%
LABD vs. TZA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | -53.78% | -70.07% | -21.43% | -41.77% | -32.68% | 1.86% | -89.75% | -70.80% | -6.26% | -75.67% |
TZA Direxion Daily Small Cap Bear 3X Shares | -46.35% | -40.22% | -32.22% | -41.19% | 30.21% | -50.80% | -80.43% | -53.25% | 25.06% | -38.19% |
Correlation
The correlation between LABD and TZA is 0.63, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.63 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.70 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.72 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.70 |
Correlation (All Time) Calculated using the full available price history since May 28, 2015 | 0.70 |
The correlation between LABD and TZA has been stable across timeframes, ranging from 0.63 to 0.72 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LABD vs. TZA — Risk / Return Rank
LABD
TZA
LABD vs. TZA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Direxion Daily Small Cap Bear 3X Shares (TZA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LABD | TZA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.05 | ||
| Sortino ratioReturn per unit of downside risk | -0.59 | ||
| Omega ratioGain probability vs. loss probability | 0.70 | 0.77 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | -1.00 | -1.00 | -0.01 |
| Martin ratioReturn relative to average drawdown | -1.37 | -1.56 | +0.19 |
Loading charts...
Drawdowns
LABD vs. TZA - Drawdown Comparison
The maximum LABD drawdown since its inception was -99.99%, roughly equal to the maximum TZA drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for LABD and TZA.
Loading charts...
Drawdown Indicators
| LABD | TZA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -100.00% | +0.01% |
Max Drawdown (1Y)Largest decline over 1 year | -86.75% | -68.07% | -18.68% |
Max Drawdown (3Y)Largest decline over 3 years | -96.40% | -89.28% | -7.12% |
Max Drawdown (5Y)Largest decline over 5 years | -98.65% | -91.56% | -7.09% |
Max Drawdown (10Y)Largest decline over 10 years | -99.99% | -99.74% | -0.25% |
Current DrawdownCurrent decline from peak | -99.99% | -100.00% | +0.01% |
Average DrawdownAverage peak-to-trough decline | -90.99% | -97.99% | +7.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 64.00% | 43.46% | +20.54% |
Volatility
LABD vs. TZA - Volatility Comparison
Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 29.98% compared to Direxion Daily Small Cap Bear 3X Shares (TZA) at 19.17%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than TZA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LABD | TZA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 29.98% | 19.17% | +10.81% |
Volatility (6M)Calculated over the trailing 6-month period | 65.23% | 42.84% | +22.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 78.79% | 58.62% | +20.17% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 96.66% | 67.66% | +29.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.97% | 68.98% | +26.99% |
LABD vs. TZA - Expense Ratio Comparison
LABD has a 1.06% expense ratio, which is lower than TZA's 1.11% expense ratio.
Dividends
LABD vs. TZA - Dividend Comparison
LABD's dividend yield for the trailing twelve months is around 9.79%, more than TZA's 5.35% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | 9.79% | 6.67% | 4.68% | 6.13% | 0.53% | 0.00% | 3.94% | 1.75% | 0.81% |
TZA Direxion Daily Small Cap Bear 3X Shares | 5.35% | 5.08% | 5.40% | 5.49% | 0.00% | 0.00% | 1.21% | 1.56% | 0.63% |
Frequently Asked Questions
LABD and TZA have a correlation of 0.63, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LABD has higher volatility (29.98%) compared to TZA (19.17%). In terms of maximum drawdown, LABD dropped -99.99% vs TZA's -100.00%.
On 10-year performance, TZA leads with -44.17% vs -59.09% for LABD. On fees, LABD is cheaper at 1.06% per year. On volatility, TZA has been the lower-risk option at 19.17%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, TZA has performed better with a -44.17% return vs -59.09%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
LABD is cheaper with a 1.06% expense ratio, compared with 1.11% for TZA.
LABD has the higher dividend yield at 9.79%, compared with 5.35% for TZA.
LABD tracks S&P Biotechnology Select Industry Index (-300%), while TZA tracks Russell 2000 Index (-300%). Their fees differ too: 1.06% for LABD and 1.11% for TZA.
LABD currently has the higher Sharpe Ratio (-1.11 vs -1.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LABD and TZA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer